Poland has been receiving COVID-19 vaccines during the coronavirus pandemic under supply contracts agreed between the European Commission and vaccine makers such as BioNTech, Pfizer and Moderna. On 19 April, the health minister said that Poland will not buy more doses of COVID-19 vaccine under the European Union’s supply contract.
Poland has seen lower vaccine uptake than most of the European Union and has surplus vaccine stock, part of which it has sold or donated to other countries. The value of the contract for vaccine supplies to Poland up to the end of 2023 with one producer alone was worth over 6 billion zlotys.
In Poland, 59% of the population has been vaccinated with two doses and 31% has received a booster shot. This is well below the EU average of 72.5% with two doses and 53% booster shot.